Stock Market News To Give You An Edge

Proven Track Record of Most Accurate Analysis

Stock Market News
To Give You An Edge​

Proven Track Record
of Most Accurate Analysis

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

MORE SHORT COVERING ON PANDORA ON THE NEWS OF A NEW CEO $P

This post was just published on ZYX Short Change Alert. Massive short squeeze is taking place in P on the news of a new CEO.  Those who can stomach draw-downs may consider temporarily moving the stop zone to $26.58 to $26.88  and adding a 10% tranche in the zone of $23 to $24.90.  The stock is at $23.30 as of this writing. Those who cannot stomach draw-downs, do not belong in this trade and should consider exiting on any pull back. There is some probability of P temporarily spiking to $40. Those who can stomach the risk and willing to hold 

Read More »

RUBICON TECHNOLOGY WILL BENEFIT AS APPLE HOME BUTTON SAPPHIRE CONFIRMED $RBCN $GTAT $AAPL

This post was published on ZYX Buy Change Alert. It is confirmed that Apple home button contains a sapphire crystal. There is no way to know at this time from which company Apple is sourcing sapphire crystals, however our estimate is that demand for sapphire crystals will go up by about 10%.  RBCN is a major provider of sapphire crystals.  Another option to keep on the radar is GTAT, a company that makes manufacturing equipment for sapphire crystals.  No recommendation is being made on GTAT at this time. As previously stated on ZYX Buy Change Alert,  consider accumulating up to 35%

Read More »

THE CHEAPER APPLE GETS, THE BETTER IT LOOKS $AAPL $BAC $CHL $CHU $CS $WMT

Yesterday, Apple announced two new iPhones, iPhone 5S and iPhone 5C.  Today, at an event in Beijing, Apple announced new iPhone availability at two smaller carriers, China Unicom and China Telecom, but no deal with the largest carrier, China Mobile.  Wall Street is venting its disappointment: Bank of America, UBS, and Credit Suisse are among the firms downgrading Apple. Shares of Apple stock are taking it hard, down more than 5.7% to $466 Wednesday afternoon, but that may just enhance Apple’s value as a stock. Here’s why. The Long Game: Tim Cook is playing the long game just like the

Read More »

TAKE PARTIAL PROFITS ON INTREPID POTASH $IPI $POT $MOS

This post was just published on ZYX Buy Change Alert. From the emails, it appears that a large number of subscribers have built up large positions in IPI.  Those holding more than 30% may consider taking partial profits right here in the zone of  $14 to $14.50.    Those holding 15% may continue to hold.

Read More »

INTREPID POTASH JUMPS $IPI

This post was just published on ZYX Buy Change Alert. IPI is jumping on news of  a large investor taking 10% passive stake.  There is also speculation of settlement in the Ukraine and Russia between potash producers. What To Do Now? Those in the stock may continue to hold. Those not in the stock may study prior posts and accumulate according to those po

Read More »

A NEW IDEA ON RUBICON AHEAD OF NEW APPLE PRODUCT LAUNCH $RBCN $AAPL

This post was just published on ZYX Buy Change Alert. There is strong speculation that Apple’s new high-end iPhone will contain a sapphire home button. This trade is for aggressive investors only as often such speculation do not turn out to be true.   RBCN manufactures mono-crystalline sapphire.  If Apple speculation turns out to be correct, RBCN can easily run to $16 to $18.  If the speculation is false, the stock can fall to $9.  On Friday the stock closed at $11.76. Consider accumulating up to 35% of full core position size in the zone of $11 to $11.80.  Stop zone

Read More »

WEEKLY MARKET DIGEST: DISAPPOINTING MOTHER OF ALL ECONOMIC NUMBERS, GOLD JUMPS $GLD $SLV $USO $DIA $SPY $QQQ $TBF $TBT

  (The Weekly Digest reproduces the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers. )  DISAPPOINTING MOTHER OF ALL ECONOMIC NUMBERS, GOLD JUMPS September 6, 2013 Monthly U. S. jobs data is known as the mother of all numbers for good reason.  First this is the data series that the Federal Reserve is targeting.  Second on the average, this data series moves the markets more than any other economic data. August Non-Farm Private Payrolls came at 152K vs. 180K consensus.  July number also revised downwards to 104K from 162K.

Read More »

ADD OR INITIATE TO KB HOME $KBH

This post was just published on ZYX Buy Change Alert. KBH is a home building.  The trigger is this morning’s employment report which is driving down interest rates.  This should reflect in mortgage rates shortly. What To Do Now? Those in this position may consider adding up to 20% in the zone of $15.80 to $16.35. Those not in the position may consider building up to 50% of the full core position size in the zone of  $15.80 to $16.35. As of this writing the stock is trading in the pre-market at $16.20.  The target remains $24 to $25 and the stop

Read More »

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy

Skip to content